EMBL Ventures
Overview
EMBL Ventures is a venture capital firm that invests throughout Europe and exclusively focuses on life-science technologies, healthcare, medical investments . The firm prefers to invest in companies operating in the biotechnology, medical technology, and life-science sectors . They manage three funds with a total of €120 million on behalf of major European private and institutional investors .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| veriNOS pharmaceuticals | Feb 2006 | VC Round | Lead |
| Crescendo Biologics Ltd. | Apr 2018 | Series B | Co-investor |
| Topas Therapeutics | Jul 2021 | Series B | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is EMBL Ventures based?
EMBL Ventures is headquartered in Heidelberg, Baden-Württemberg, Germany.
When was EMBL Ventures founded?
EMBL Ventures was founded in 2001.
How many portfolio companies does EMBL Ventures have?
EMBL Ventures has 4 portfolio companies in Caplight's dataset.
What are some companies in EMBL Ventures's portfolio?
Portfolio companies visible on Caplight include veriNOS pharmaceuticals, Crescendo Biologics Ltd., Topas Therapeutics.
What was EMBL Ventures's most recent investment shown here?
EMBL Ventures's most recent investment in this portfolio sample was in Topas Therapeutics in 2021.
What sectors does EMBL Ventures focus on?
EMBL Ventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does EMBL Ventures focus on?
EMBL Ventures typically invests at the Mid stage.
What is EMBL Ventures's AUM?
EMBL Ventures's assets under management are estimated between $100.0M and $250.0M.